A clinical prediction model for hospitalized COPD exacerbations based on “treatable traits”

References

• DalalAChristensenLLiuFRiedelAADirect costs of chronic obstructive pulmonary disease among managed care patientsInt J Chron Obstruct Pulmon Dis2010534134921037958
   PubMedGoogle Scholar
• SeemungalTADonaldsonGCPaulEABestallJCJeffriesDJWedzi-chaJAEffect of exacerbation on quality of life in patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med19981575 Pt 1141814229603117
   PubMed Web of Science ®Google Scholar
• MiravitllesMFerrerMPontAEffect of exacerbations on quality of life in patients with chronic obstructive pulmonary disease: a 2 year follow up studyThorax200459538739515115864
   PubMed Web of Science ®Google Scholar
• DransfieldMTKunisakiKMStrandMJAcute exacerbations and lung function loss in smokers with and without chronic obstructive pulmonary diseaseAm J Respir Crit Care Med20171953330
   Web of Science ®Google Scholar
• SuissaSdell’anielloSErnstPLong-term natural history of chronic obstructive pulmonary disease: severe exacerbations and mortalityThorax2012671195796322684094
   PubMed Web of Science ®Google Scholar
• Global Initiative for Chronic Obstructive Lung Disease (GOLD)GOLD 2018 global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2018 report2018
   Google Scholar
• HurstJRVestboJAnzuetoASusceptibility to exacerbation in chronic obstructive pulmonary diseaseN Engl J Med2010363121128113820843247
   PubMed Web of Science ®Google Scholar
• BafadhelMMckennaSTerrySAcute exacerbations of chronic obstructive pulmonary disease: identification of biologic clusters and their biomarkersAm J Respir Crit Care Med2011184666267121680942
   PubMed Web of Science ®Google Scholar
• ViniolCVogelmeierCFExacerbations of COPDEur Respir Rev20182714717010329540496
   PubMed Web of Science ®Google Scholar
• AgustiABelEThomasMTreatable traits: toward precision medicine of chronic airway diseasesEur Respir J201647241041926828055
   PubMed Web of Science ®Google Scholar
• HanMKQuibreraPMCarrettaEEFrequency of exacerbations in patients with chronic obstructive pulmonary disease: an analysis of the SPIROMICS cohortLancet Respir Med20175861962628668356
   PubMed Web of Science ®Google Scholar
• Le RouzicORocheNCortotABDefining the “Frequent Exac-erbator” phenotype in COPD: a hypothesis-free approachChest201815351106111529054347
   PubMed Web of Science ®Google Scholar
• WoodruffPGBarrRGBleeckerEClinical significance of symptoms in smokers with preserved pulmonary functionN Engl J Med2016374191811182127168432
   PubMed Web of Science ®Google Scholar
• MillerMRHankinsonJBrusascoVStandardisation of spirometryEur Respir J200526231933816055882
   PubMed Web of Science ®Google Scholar
• MorrisJFKoskiAJohnsonLCSpirometric standards for healthy nonsmoking adultsAm Rev Respir Dis1971103157675540840
   PubMed Web of Science ®Google Scholar
• PellegrinoRViegiGBrusascoVInterpretative strategies for lung function testsEur Respir J200526594896816264058
   PubMed Web of Science ®Google Scholar
• BurgeSWedzichaJACOPD exacerbations: definitions and classificationsEur Respir J Suppl20034146s53s12795331
   PubMedGoogle Scholar
• AdamsSTLevesonSHClinical prediction rulesBMJ2012344d831222250218
   PubMed Web of Science ®Google Scholar
• PuhanMAGarcia-AymerichJFreyMExpansion of the prognostic assessment of patients with chronic obstructive pulmonary disease: the updated bode index and the ado indexThe Lancet20093749691704711
   PubMed Web of Science ®Google Scholar
• JonesRCDonaldsonGCChavannesNHDerivation and validation of a composite index of severity in chronic obstructive pulmonary disease: the dose indexAm J Respir Crit Care Med2009180121189119519797160
   PubMed Web of Science ®Google Scholar
• DijkWDBemtLHaak-RongenSMultidimensional prognostic indices for use in COPD patient care. A systematic reviewRespir Res201112115122082049
   PubMed Web of Science ®Google Scholar
• MotegiTJonesRCIshiiTA comparison of three multidimensional indices of COPD severity as predictors of future exacerbationsInt J Chron Obstruct Pulmon Dis2013825927123754870
   PubMed Web of Science ®Google Scholar
• JonesRCPriceDChavannesNHMulti-component assessment of chronic obstructive pulmonary disease: an evaluation of the ado and dose indices and the global obstructive lung disease categories in international Primary care data setsNPJ Prim Care Respir Med20162611601027053297
   PubMed Web of Science ®Google Scholar
• Montserrat-CapdevilaJGodoyPMarsalJRBarbéFGalvánLRisk factors for exacerbation in chronic obstructive pulmonary disease: a prospective studyInt J Tuberc Lung Dis201620338939527046722
   PubMed Web of Science ®Google Scholar
• MüllerovaHMaselliDJLocantoreNHospitalized exacerbations of COPDChest20151474999100725356881
   PubMed Web of Science ®Google Scholar
• ChuCMChanVLLinAWWongIWLeungWSLaiCKReadmission rates and life threatening events in COPD survivors treated with non-invasive ventilation for acute hypercapnic respiratory failureThorax200459121020102515563699
   PubMed Web of Science ®Google Scholar
• MinovJStoleskiSMijakoskiDVasilevskaKAtanasovskaAExacerbations in COPD patients with bronchiectasisMedical Sciences2017527
   Google Scholar
• NiYShiGYuYHaoJChenTSongHClinical characteristics of patients with chronic obstructive pulmonary disease with comorbid bronchiectasis: a systemic review and meta-analysisInt J Chron Obstruct Pulmon Dis2015101465147526251586
   PubMed Web of Science ®Google Scholar
• DielRJacobJLampeniusNBurden of non-tuberculous myco-bacterial pulmonary disease in GermanyEur Respir J2017494160210928446559
   PubMed Web of Science ®Google Scholar
• HuangCTTsaiYJWuHDImpact of non-tuberculous mycobac-teria on pulmonary function decline in chronic obstructive pulmonary diseaseInt J Tuberc Lung Dis201216453954522325332
   PubMed Web of Science ®Google Scholar
• PoolerABeechRExamining the relationship between anxiety and depression and exacerbations of COPD which result in hospital admission: a systematic reviewInt J Chron Obstruct Pulmon Dis2014931533024729698
   PubMed Web of Science ®Google Scholar
• McgarveyLLeeAJRobertsJGruffydd-JonesKMcknightEHaughneyJCharacterisation of the frequent exacerbator phenotype in COPD patients in a large UK primary care populationRespir Med2015109222823725613107
   PubMed Web of Science ®Google Scholar
• WanESDemeoDLHershCPClinical predictors of frequent exacerbations in subjects with severe chronic obstructive pulmonary disease (COPD)Respir Med2011105458859421145719
   PubMed Web of Science ®Google Scholar
• JonesPWMullerovaHAgustiACardiovascular disease does not predict exacerbation rate or mortality in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2018197340040328665686
   PubMed Web of Science ®Google Scholar
• PatelARCDonaldsonGCMackayAJWedzichaJAHurstJRThe impact of ischemic heart disease on symptoms, health status, and exacerbations in patients with COPDChest2012141485185721940771
   PubMed Web of Science ®Google Scholar
• MakeBJErikssonGCalverleyPMA score to predict short-term risk of COPD exacerbations (SCOPEX)Int J Chron Obstruct Pulmon Dis20151020120925670896
   PubMed Web of Science ®Google Scholar
• EchevarriaCSteerJHeslop-MarshallKThe pearl Score predicts 90-day readmission or death after hospitalisation for acute exacerbation of COPDThorax201772868669328235886
   PubMed Web of Science ®Google Scholar
• MurphyPBRehalSArbaneGEffect of home noninvasive ventilation with oxygen therapy vs oxygen therapy alone on hospital readmission or death after an acute COPD exacerbationJAMA2017317212177218628528348
   PubMed Web of Science ®Google Scholar
• PolverinoEGoeminnePCMcdonnellMJEuropean Respiratory Society guidelines for the management of adult bronchiectasisEur Respir J2017503170062928889110
   PubMed Web of Science ®Google Scholar
• AlbertRKConnettJBaileyWCAzithromycin for prevention of exacerbations of COPDN Engl J Med2011365868969821864166
   PubMed Web of Science ®Google Scholar
• KellyCChalmersJDCrossinghamIMacrolide antibiotics for bronchiectasisCochrane Database Syst Rev20183CD01240629543980
   PubMedGoogle Scholar
• BhattSPWellsJMKinneyGLβ-Blockers are associated with a reduction in COPD exacerbationsThorax201671181426283710
   PubMed Web of Science ®Google Scholar
• duQSunYDingNLuLChenYBeta-blockers reduced the risk of mortality and exacerbation in patients with COPD: a meta-analysis of observational studiesPLoS One2014911e11304825427000
   PubMed Web of Science ®Google Scholar
• RuttenFHZuithoffNPHakEGrobbeeDEHoesAWBeta-blockers may reduce mortality and risk of exacerbations in patients with chronic obstructive pulmonary diseaseArch Intern Med20101701088088720498416
   PubMed Web of Science ®Google Scholar
• CouillardSLarivéePCourteauJVanasseAEosinophils in COPD exacerbations are associated with increased readmissionsChest2017151236637327746201
   PubMed Web of Science ®Google Scholar
• EffingTWKerstjensHAMMonninkhofEMDefinitions of exacerbationsChest2009136391892319736196
   PubMed Web of Science ®Google Scholar